| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9319377 | European Urology | 2005 | 7 Pages |
Abstract
OM-89 significantly reduced the incidence of UTI during the 12 months of the study including 3 months of treatment and three 10-day booster courses. These results confirm that OM-89 is a valuable component of the management of recurrent UTI.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Hartwig W. Bauer, Schanaz Alloussi, Günther Egger, Hans-Martin Blümlein, Gabriel Cozma, Claude C. Schulman, on behalf of the Multicenter UTI Study Group on behalf of the Multicenter UTI Study Group,